Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H
- PMID: 24418547
- PMCID: PMC4104721
- DOI: 10.1016/j.virol.2013.10.037
Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H
Abstract
Previous studies have shown that apolipoprotein B mRNA editing, enzyme catalytic, polypeptide G (APOBEC3G; hA3G) and F (APOBEC3F; hA3F) proteins interact with a nonlinear binding site located at the N-terminal region of the HIV-1 Vif protein. We have analyzed the role of 12 positively charged amino acids of the N-terminal region of the SIV Vif. Simian-human immunodeficiency viruses (SHIV) were constructed that expressed each of these amino acid substitutions. These viruses were examined for replication in the presence of rhesus macaque APOBEC3 proteins (rhA3A-rhA3H), incorporation of the different A3 proteins into virions, and replication in rhesus macaque PBMC. Similar to other studies, we found that K27 was essential for rhA3G activity and rhA3F but was not important for restriction of SHIVΔvif by rhA3A, rhA3D or rhA3H. Our results identified the arginine at position 14 of the SIV Vif as a critical residue for virus restriction by rhA3D, rhA3G and rhA3H.
Keywords: APOBEC3 proteins; Amino terminus; HIV-1; SHIV; SIV; Structure–function; Vif; Virus restriction.
© 2013 Elsevier Inc. All rights reserved.
Figures















Similar articles
-
Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors.J Virol. 2012 Mar;86(5):2874-7. doi: 10.1128/JVI.06950-11. Epub 2011 Dec 28. J Virol. 2012. PMID: 22205746 Free PMC article.
-
Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.J Virol. 2006 Jun;80(12):5984-91. doi: 10.1128/JVI.00388-06. J Virol. 2006. PMID: 16731937 Free PMC article.
-
Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.J Virol. 2016 Oct 28;90(22):10193-10208. doi: 10.1128/JVI.01497-16. Print 2016 Nov 15. J Virol. 2016. PMID: 27581978 Free PMC article.
-
Advances in the structural understanding of Vif proteins.Curr HIV Res. 2008 Mar;6(2):91-9. doi: 10.2174/157016208783885056. Curr HIV Res. 2008. PMID: 18336256 Free PMC article. Review.
-
APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.Med Sci Monit. 2006 May;12(5):RA92-8. Med Sci Monit. 2006. PMID: 16641889 Review.
Cited by
-
Analysis of Select Herpes Simplex Virus 1 (HSV-1) Proteins for Restriction of Human Immunodeficiency Virus Type 1 (HIV-1): HSV-1 gM Protein Potently Restricts HIV-1 by Preventing Intracellular Transport and Processing of Env gp160.J Virol. 2018 Jan 2;92(2):e01476-17. doi: 10.1128/JVI.01476-17. Print 2018 Jan 15. J Virol. 2018. PMID: 29093081 Free PMC article.
-
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage.Antimicrob Agents Chemother. 2015 Aug;59(8):4870-81. doi: 10.1128/AAC.00137-15. Epub 2015 Jun 8. Antimicrob Agents Chemother. 2015. PMID: 26055363 Free PMC article.
References
-
- Ara T, Itoi M, Kawabata K, Egawa T, Tokoyoda K, Sugiyama T, Fujii N, Amagai T, Nagasawa T. A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo. J. Immunol. 2003;170:4649–4655. - PubMed
-
- Betts L, Xiang S, Short SA, Wolfenden R, Carter CW., Jr. Jan. Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex. J. Mol. Biol. 1994;235:635–656. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources